Purchase Order 75N95022P00038
Award Date
11/30/21
Potential Completion Date
11/29/22
Potential Value
$181K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Activx Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
La Jolla, CA 92037, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Activx Biosciences, Inc. is a $148,200 firm fixed-price purchase order for native kinase full panel profiling of 57 compounds. The contract was set aside for small businesses and has a completion date of July 2, 2020. Activx Biosciences, a foreign-owned for-profit biopharmaceutical company, provides drug discovery and development...
This is a federal contract award to Activx Biosciences, Inc. by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the U.S. Department of Health and Human Services. The $10,850 Firm Fixed Price contract is a replacement award for a previous contract (75N94020P00619) and has a completion date of September 30, 2020. Activx Biosciences is a foreign-owned, for-profit biopharmaceutical company that specializes in drug discovery and development services, with...
This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Proteros Biostructures GMBH, a foreign-owned for-profit organization and manufacturer of goods. The contract is for $38,035.00 and is for x-ray structure analyses of eEF1A2 and c-Abl in complex with ligands. The contract was awarded on September 3, 2015 and has a completion date of September 7, 2016....
This $29,376 firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Reaction Biology Corporation, a self-certified small disadvantaged business. The award is to obtain kinase hotspot assay compound testing services from Reaction Biology. This contract is not associated with a larger vehicle. The purpose is to test 120 novel small molecule compounds for inhibitory activity...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, has awarded a $1,785,000.00 firm fixed price purchase order contract to X-Chem, Inc., a for-profit drug discovery company. The 8-month contract, which runs from May 2023 through January 2024, does not have a set-aside designation. Based on X-Chem's prior work as a subcontractor on federal grants focused on early-stage drug discovery research, the contract likely...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to AAT Bioquest, Inc., a minority-owned, for-profit, woman-owned small business, and Asian-Pacific American-owned manufacturer of goods. The contract, valued at $161,032.00, is for products or services related to the NIH's mission of accelerating the translation of research to improve human health. The contract does not have a set-aside designation and...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Cyprotex US LLC, a foreign-owned for-profit organization, for $153,215.00 to conduct testing of compounds in absorption, distribution, metabolism, and excretion (ADME) assays over a 1-year period from March 5, 2021 to March 4, 2022. The contract was awarded sole-source without full and open...
This is a $118,430.00 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Reaction Biology Corporation, a self-certified small disadvantaged business. The contract is for testing 15 novel small molecule compounds using Reaction Biology's proprietary Kinase HotSpot assay platform. This work supports translational research efforts across the NIH. The purchase order was...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Eurofins Discoverx Products, LLC, a foreign-owned, self-certified small disadvantaged business, for a PathHunter Detection Kit. The potential value of the contract is $30,778.40, with a completion date of August 25, 2021. The services provided under this contract appear to be in support of the agency's mission of advancing...